NCT00511108 Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061) Status COMPLETED Phase PHASE1
NCT00509262 Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) Status COMPLETED Phase PHASE3
NCT00509236 Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) Status COMPLETED Phase PHASE3
NCT00508664 Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) Status COMPLETED Phase PHASE2
NCT00506987 Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887) Status COMPLETED Phase PHASE2
NCT00506545 Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888) Status COMPLETED Phase PHASE2
NCT00506389 A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707) Status COMPLETED Phase PHASE3
NCT00506077 MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016) Status COMPLETED Phase PHASE2
NCT00505843 A Study of MK0657 in Parkinson's Disease Patients (0657-006) Status COMPLETED Phase PHASE1
NCT00505245 New Assessment System in Measuring Symptom Distress in Cancer Patients Status RECRUITING Phase N/A
NCT00504166 Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women Status COMPLETED Phase PHASE4
NCT00503971 Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib. Status TERMINATED Phase PHASE1/PHASE2
NCT00501657 Effects of Sitagliptin on Gastric Emptying in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00501306 Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men Status COMPLETED Phase N/A
NCT00500006 A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED) Status TERMINATED Phase PHASE1
NCT00496626 An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00496353 MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED) Status COMPLETED Phase PHASE1/PHASE2
NCT00496327 Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056) Status COMPLETED Phase PHASE3
NCT00496093 Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011) Status COMPLETED Phase PHASE3